title: Assessment of attitudes towards methadone maintenance treatment between heroin users at a compulsory detoxification centre and methadone maintenance clinic in Ningbo, China.
abstract: BACKGROUND
  In China, the Compulsory Detoxification Centres are the main response for people who use illegal drugs. Due to high relapse rates among people released from the Compulsory Detoxification Centres, it is likely that they may seek medical help, including Methadone Maintenance Treatment (MMT) services, at some point. Therefore, better understanding of the attitudes and beliefs of people in the Compulsory Detoxification Centres can help to provide more adequate response to opioid dependence.
  
  
  METHODS
  In total, 329 detained heroin users and 112 active MMT clients were recruited from a local Compulsory Detoxification Centre and MMT clinic, respectively. The survey contained specific questions relating to attitudes and beliefs regarding MMT.
  
  
  RESULTS
  Participants at the Compulsory Detoxification Centre and the MMT clinic expressed different opinions, regarding positive and negative attitudes and beliefs towards MMT. In addition, participants from both sites hold certain negative attitudes and beliefs about methadone despite their acknowledgement of the positive effects of MMT. Finally, participants at the Compulsory Detoxification Centre and the MMT clinic reported distinctive treatment preferences, with the former preferring community-based treatment and the latter MMT.
  
  
  CONCLUSIONS
  Developing targeted education about MMT for people at the Compulsory Detoxification Centres could help improve access to accurate and evidence-based health and treatment information. The study may also help providers understand and adjust services needed for target population in the future.
authors.affiliation: Ningbo University School of Medicine, 818 Fenghua Street, Jiangbei District, Ningbo, Zhejiang, China.
authors.forename: Yu
authors.initials: Y
authors.lastname: Liu
authors.forename: Longhui
authors.initials: L
authors.lastname: Li
authors.forename: Yahai
authors.initials: Y
authors.lastname: Zhang
authors.forename: Lina
authors.initials: L
authors.lastname: Zhang
authors.forename: Wenwen
authors.initials: W
authors.lastname: Shen
authors.forename: Huachong
authors.initials: H
authors.lastname: Xü
authors.forename: Guangming
authors.initials: G
authors.lastname: Wang
authors.forename: Weidong
authors.initials: W
authors.lastname: Lü
authors.forename: Wenhua
authors.initials: W
authors.lastname: Zhou
mesh_terms: D000293:Adolescent; D000328:Adult; D002681:China; D055030:Drug Users / Q000331:legislation & jurisprudence / Q000523:psychology*; D005260:Female; D007722:Health Knowledge, Attitudes, Practice; D006556:Heroin Dependence / Q000188:drug therapy; D006801:Humans; D008297:Male; D008691:Methadone / Q000627:therapeutic use*; D008875:Middle Aged; D058850:Opiate Substitution Treatment / Q000523:psychology*; D016320:Substance Abuse Treatment Centers / Q000331:legislation & jurisprudence*
chemical_list: D008691:Methadone
references.citation: Lancet. 2010 Jul 24;376(9737):285-301
references.pmid: 20650522
references.citation: Addiction. 1997 Oct;92(10):1353-60
references.pmid: 9489052
references.citation: Ann N Y Acad Sci. 2004 Oct;1025:439-45
references.pmid: 15542747
references.citation: Psychiatr Serv. 2001 Sep;52(9):1223-9
references.pmid: 11533397
references.citation: Health Technol Assess. 2007 Mar;11(9):1-171, iii-iv
references.pmid: 17313907
references.citation: Int J Drug Policy. 2007 Mar;18(2):118-28
references.pmid: 17689354
references.citation: J Subst Abuse Treat. 2002 Dec;23(4):327-34
references.pmid: 12495794
references.citation: Am J Drug Alcohol Abuse. 2008;34(2):127-31
references.pmid: 18293229
references.citation: J Subst Abuse Treat. 2007 Dec;33(4):373-8
references.pmid: 17499960
references.citation: West J Med. 1990 May;152(5):588-99
references.pmid: 2190427
references.citation: Am J Drug Alcohol Abuse. 2009;35(5):368-74
references.pmid: 20180666
references.citation: Int J Drug Policy. 2010 Jan;21(1):36-42
references.pmid: 18805686
references.citation: Int J Drug Policy. 2010 May;21(3):149-54
references.pmid: 19896818
references.citation: Lancet. 2010 Aug 7;376(9739):475-85
references.pmid: 20650514
references.citation: Int J Drug Policy. 2010 Mar;21(2):122-4
references.pmid: 19931444
references.citation: J Psychoactive Drugs. 1998 Jan-Feb;30(1):89-97
references.pmid: 9565212
references.citation: PLoS Med. 2008 Dec 9;5(12):e234
references.pmid: 19071954
references.citation: J Psychoactive Drugs. 1988 Jul-Sep;20(3):275-81
references.pmid: 3069986
references.citation: Addiction. 2010 Feb;105(2):216-23
references.pmid: 20078480
references.citation: Am J Addict. 2008 Sep-Oct;17(5):396-401
references.pmid: 18770082
references.citation: Drug Alcohol Rev. 2009 Nov;28(6):641-7
references.pmid: 19930018
references.citation: Addiction. 2006 May;101(5):657-65
references.pmid: 16669899
references.citation: Int J Environ Res Public Health. 2009 Feb;6(2):787-97
references.pmid: 19440415
references.citation: Lancet. 2010 Mar 20;375(9719):1014-28
references.pmid: 20189638
references.citation: Int J Addict. 1985 Nov-Dec;20(11-12):1751-71
references.pmid: 3833809
references.citation: J Clin Psychol. 1997 Jun;53(4):387-97
references.pmid: 9169394
references.citation: Int J Addict. 1980 Oct;15(7):1003-9
references.pmid: 7450944
references.citation: Addiction. 1998 Jan;93(1):51-60
references.pmid: 9624711
references.citation: J Urban Health. 2002 Dec;79(4):571-8
references.pmid: 12468676